FIT (Farmacology, Immunotherapy, Nanotoxicology) (Q19845)

From EU Knowledge Graph
Revision as of 17:23, 22 October 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): The project is part of the VÚVeL concept to build the European Research Centre for Veterinary and Preclinical Medicine. The aim of the project is to prepare a leading team and infrastructure for oriented basic research in the field of use of nanotechnology in biomedicine and in the new scientific field of nanotoxicology. The strategic intention of the VÚVeL is to build a European Research Centre focused on research and development of modern vacc...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
FIT (Farmacology, Immunotherapy, Nanotoxicology)
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    171,588,633.0 Czech koruna
    0 references
    6,863,545.32 Euro
    10 January 2020
    0 references
    201,868,980.0 Czech koruna
    0 references
    8,074,759.2 Euro
    10 January 2020
    0 references
    85 percent
    0 references
    1 January 2017
    0 references
    31 December 2021
    0 references
    31 December 2021
    0 references
    Výzkumný ústav veterinárního lékařství, v. v. i.
    0 references
    0 references

    49°15'11.38"N, 16°34'51.89"E
    0 references
    62100
    0 references
    Projekt je součástí konceptu VÚVeL na vybudování Evropského Výzkumného Biomedicínského Centra pro veterinární a preklinické medicíny. Cílem projektu je připravit špičkový tým a infrastrukturu pro orientovaný základní výzkum v oblasti využití nanotechnologií v biomedicíně i v nové vědecké oblasti nanotoxikologie. Strategickým záměrem VÚVeL je vybudování Evropského Výzkumného Centra zaměřeného na výzkum a vývoj moderních vakcín, diagnostik a terapeutik pro infekční choroby a nebezpečné zoonózy. a. (Czech)
    0 references
    The project is part of the VÚVeL concept to build the European Research Centre for Veterinary and Preclinical Medicine. The aim of the project is to prepare a leading team and infrastructure for oriented basic research in the field of use of nanotechnology in biomedicine and in the new scientific field of nanotoxicology. The strategic intention of the VÚVeL is to build a European Research Centre focused on research and development of modern vaccines, diagnostics and therapeutics for infectious diseases and dangerous zoonoses. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.02.1.01/0.0/0.0/15_003/0000495
    0 references